Chapter 175 - Gonorrhea, Mycoplasma, and Vaginosis Flashcards
Most commonly reported STD
Chlamydia
Most common cause of PID in women
Chlamydia
Neisseria gonorrhoeae is a Gram ___ aerobic diplococci located intracellularly in PMNs
Negative
2nd most commonly reported infectious disease in the US
Gonorrhea
The highest rate of reported gonococcal infections is among secually active teenagers and young adults, aged ___
15 to 24 years old
The rate in African Americans is __ times higher than whites and in Hispanics ___ times than in whites
20x; 2x
Important risk factor for acquisition of new gonococcal infection
Prior Gonorrhea infection (recidivism)
Incubation period of gonorrhea
2 to 8 days
___% of men and ___% of women have asymptomatic Gonorrhea
10%; 50%
The most common manifestation of gonoccoal infection in men is
Urethritis
Spontaneous profuse cloudy discharge from penile meatus
Entire distal penis may sometimes become swollen termed as
Bull head clap
Testicular pain or orchitis may be the only presenting symptom for gonorrhea.
True or False
True, but more commonly with combined infection with Chlamydia
Common site of local infection of gonorrhea in women
Endocervix
Vaginitis is commonly seen in gonorrhea. True or False
False, only in prepubertal girls or postmenopausal women as vaginal epithelium of sexually mature women does not support growth of N. Gonorrhoeae
Classic triad of disseminated gonococcal infection present in 0.5% to 3% of cases
Dermatitis
Migratory polyarthritis
Tenosynovitis
Macules or vesiculopustules on an erythematous base located on palms and soles with necrotic centers is often described as
‘Gun metal gray’
PID occurs in about ___% of uncomplicated gonorrheal infections in women
10-40%
Sequela of PID (4)
Tubo-ovarian abscesses
Ectopic pregnancies
Chronic pelvic pain
Infertility
Inflammation of liver capsule present in 1/4 of women with PID secondary to Chlamydia or Neisseria
Fitz Hugh Curtis Syndrome
Mainfestation of Fitz Hugh Curtis syndrome
RUQ pain/tenderness
Abnormal LFTs
True septic arthritis caused by Neisseria gonorrhoeae is typically polyarticular.
True or False
False, monoarticular or pauciarticular
In gonococcal endocarditis affecting 1-2% of disseminated cases, vegetations primarily affect the ___ in young male patients
Aortic valve
Profuse purulent discharge common in newborns of mothers with gonococcal infection
Ophthalmia neonatorum
Prophylaxis for ophthalmia neonatorum
Erythromycin 0.5% ophthalmic ointment both eyes immediately after birth
Or
Ceftriaxone 25-50mg/kg IV or IM in a single dose (not to exceed 125 mg)
Permanent sequelae of gonococcal infection in women (2)
Infertility
Increased risk of ectopic pregnancies
Pathogenesis of gonococcal infection involves bacterial attachment to columnar cells via (2)
Pili (pilC and Opa)
Fimbriae
Contributes to pathogenesis of disseminated gonococcal infection
Endotoxin
Aside from ophthalmia neonatorum, neonatal gonococcal infection can lead to (4)
Growth retardation LBW Prematurity Blindness Infant death
Gram stain for gonococcal infection has high specificity (>___%) and high sensitivity (___%) hence considered diagnostic for infection
99%; 95%
A negative Gram stain rules out gonococcal infection in asymptomatic men at high risk for infection.
True or False
False, cannot
Best specimen for gram staining for diagnosis of gonococcal infection
Urethra specimen
Never vaginal!!!
Cervical, not used for screening!
Gold standard culture for N. Gonorrhoeae required (4)
Nicotinamide adenine dinucleotide
Heme
Yeast extract
CO2
Used to provide more rapid diagnosis in STI clinics
NAAT (nucleic acid amplification tests)
First line treatment for gonorrhoeae according to CDC (2015)
Azithromycin 1g PO single dose
+ Ceftriaxone 250mg IM single dose
__% of people with gonorrhoeae also are coninfected with Chlamydia
10-30%
Recommended CDC regimen for DGI affecting joints
Azithromycin 1g PO single dose
Ceftriaxone 1g IM/IV q 24h for 7 days
Recommended CDC regimen for DGI endocarditis/meningitis
1g Azithromycin PO single dose
+ Ceftriaxone 1-2 g IV q 12-24h for 10-14 days
Allergic reactions are common with 3rd gen cephalosporins.
True or False
False, uncommon
Alternative for Cephalosporin in cases of IgE mediated penicillin allergy
Gemifloxacin 320mg PO \+ Azithromycin 2g PO OR Gentamicin 240mg IM \+ Azithromycin 2g PO
Yearly Screening recommendation of CDC for gonorrhea for the ff (5)
- Men who engages in receptive anal intercourse
- All sexually active women younger than 25 years old
- Any woman with a new sex partner
- Multiple sex partner
- Partner with STI
Treatment of gonococcal infection in neonates
Ceftriaxone 25-50mkday IV/IM in single daily dose for 7 or 10-14 days if meningitis is documented
OR
Cefotaxime 25 mkday IV/IM BID for 7 days or 10-14 days
Smallest free-living self-replicating bacteria which lacks a cell wall that colonize repiratory/urogenital tracts of humans
Mycoplasma
- Mycoplasma spp.
- Ureaplasma spp.
Most common Mycoplasma strains isolated from genital tract
Mycoplasma hominis (P100): 20-50% of sexually active women Mycoplasma genitalium (P110 and P140): 1% to 6.4%
Most common cause of synptomatic nongonococcal urethritis
#1Chlamydia spp #2 Ureaplasma #3 M. Genitalium
Most common cutaneous disease in men with mycoplasma infection; in women
Urethritis; Cervicitis
Disseminated Mycoplasma infection in immunocompromised hosts leads to (3)
Respiratory tract infection
Osteomyelitis
Infectious arthritis
Associated with bacteremia after renal transplantation, surgical wound infections, pericardial effusions, prosthetic heart valves, subcutaneous abscesses, synovial fluid with rheumatoid arthritis
Mycoplasma hominis
Causative role in female infertility
M. Hominis
Ureaplasma
M. Genitalium infection leads to male infertility.
True or False
False, unknown
Req’t for growth of Mycoplasma and of Ureaplasma
Cholesterol and urea
Mycoplasma take ___ mos to speciate
6, slow-growing
Preferred method of testing for Mycoplasma infection
Nucleic acid amplification test, first voided urine
Standard of care for Mycoplasma infection
Empiric treatment in persistent or recurrent urethritis, cervicitis, and PID
Detection of Mycoplasma antibodies denotes active infection.
True or False
False, denotes prior colonization or cross reaction but increasing titer for acute infection
Treatment of Mycoplasma urethritis
Azithromycin 1g PO single dose
Azithromycin 500mg PO on day 1 + 250mg PO for 4 days
Or
Moxifloxacin 400 mg/day for 7-14 days
CDC recommendation for PID unresponsive to standard treatment
Moxifloxacin 400 mg PO for 14 days
Chlamydia primarily affects mucous membranes of 3 systems
Ophthalmic
Genitourinary
respiratory
Used to monitor prevalence of Chlamydia infection
NHANES
National Health and Nutrition Examination Survey
The prevalence of Chlamydia infection in sexually active women is ___ proportional to age with highest rates between ages of
Inversely; 14-24 years old
Most common manifestation of C. Trachomatis infection
Urogenital infection
Most common site of infection in men for Chlamydia is __; in women, is ___
Urethra; urethra and cervix
Most common cause of epididymitis in male patients younger than 35 years of age
C. Trachomatis
N. Gonorrhoeae
Unilateral testicular pain and swelling with dysuria and fever
Epididymitis
Proctitis limited to rectum presenting with pruritus, pain, mucopurulent discharge is caused by serovars
Serovar D-K of C. Trachomatis
PID is a combination of (3)
Endometritis
Salpingitis
Peritonitis
Perinatal infection of Chlamydia may result to (2)
Conjunctivitis
Pneumonia
Neonatal chlamydial penumonia presents within __ after birth with tachypnea, nasal symptoms and staccato cough. No wheezing. (+) peripheral eosinophilia
8 weeks
Immune mediated arthritis resulting from mucosal infection (urethritis), concomitant conjunctivitis, and cutaneous lesions involving the genitals
Reactive arthritis
Increased risk of developing reactive arthritis
HLAB27 individuals
C. Trachomatis is a nonmotile Gram (___) intracellular bacteria that replicates in human cells
Negative
2 phase life cycle of Chlamydia
Elementary body —> Reticulate body in 6-8 hours
Matching type
- LGV
- Chronic conjunctivitis
- Urogenital tract infection
- Trachoma
A. A to C
B. D to K
C. L1 to L3
C
A
B
A
Chlamydia symptoms occur __ after exposure
1-3 weeks
Preferred method of testing for Chlamydia infections
NAAT of urethral specimen in men and endocervical or vaginal in women
Nucleic acid amplification test
NAAT is most sensitive test availble and as almost as specific as culture.
True or False
True
NAAT remains positive __ after treatment
3 weeks
First line treatment for Chlamydia infection
Doxycycline 100 mg PO BID for 7 days
Or
azithromycin 1 g PO single dose
CDC recommends retest at __ or wirhin at least ___ of treatment
3 months; at least 1 year
Most recurrences are the result of treatment failure.
True or False
False, reinfection
CDC recommendation for screening
Annual screening for
- Sexually active women younger than 25 years old
- Older women with risk factors (new or multiple partners)
Most common vaginal infection in women 15 to 44 years old
Bacterial vaginosis
Most common risk factors for bacterial vaginosis (2)
Having sex at an early age
New or multiple sex partners
Protective against development of bacterial vaginosis
Hormonal contraception
Estrogen-progestin/progestin
Help maintain acidic pH of vagina
Lactobacilli
In bacterial vaginosis, lactobacilli is replaced by (7)
Gram (-) anaerobic bacteria 1. Gardnerella vaginalis 2. M. Hominis 3. M. Curtisii Gram (-) anaerobic rods 1. Prevotella 2. Porphyromonas 3. Bacteroides 4. Peptostreptococus
__% of bacterial vaginosis infections are asymptomatic
84
Amsel criteria for bacterial vaginosis should satisfy 3 out of 4 findings
- Profuse milky vaginal discharge
- (+) whiff test result exposed to 10-20% KOH
- Vaginal pH greater than 4.5
- Clue cells greater than 2% on microscopic examination
Most reliable indicator of BV
At least 20% of epithelial cells on saline wet mount
Sensitivity of 92.8% and specificity of 85.7% for BV
DNA probe-based test (16SrRNA gene)
100% sensitivity compared with Amsel’s criteria
AmpliSens Florocenosis/
Bacterial vaginosis-FRT multiplex real time PCR
Treatment of asymptomatic non pregnant women is not necessary.
True or False
True
Treatment of BV
Metronidazole 500 mg BID x 7 days
Metronidazole 0.75% gel 5g intravaginally OD x 5 days
Tinidazole 2g PO OD x 3 days
Clindamycin 5% cream 5g intra vaginally OD x 7 days
Treatment of BV in pregnant women
Metronidazole 250 mg PO TID x 7 days
Metronidazole 500 mg PO BID x 7 days
Clindamycin 300 mg BID x 7 days